Patient-specific induced pluripotent stem cells (iPSCs) hold great promise for many
applications, including disease modeling to elucidate mechanisms involved in disease …

The advent of iPSCs has brought about a significant transformation in stem cell research,
opening up promising avenues for advancing cancer treatment. The formation of cancer is a …

In Japan, a research center network consisting of Kyoto University to provide clinical-grade
induced Pluripotent Stem Cells (iPSC) and several major research centers to develop iPSC …

Stem cells are classified into embryonic stem cells and adult stem cells. An evolving
alternative to conventional stem cell therapies is induced pluripotent stem cells (iPSCs) …

The discovery of somatic cell nuclear transfer proved that somatic cells can carry the same
genetic code as the zygote, and that activating parts of this code are sufficient to reprogram …

The development of induced pluripotent stem cells (iPSCs) by Shinya Yamanaka and
colleagues in 2006 has led to a potential new paradigm in cellular therapeutics, including …

Induced pluripotent stem cells (iPSCs) hold great promise for autologous cell therapies, but
significant roadblocks remain to translating iPSCs to the bedside. For example, concerns …

The development of immunotherapeutic monoclonal antibodies targeting checkpoint
inhibitory receptors, such as programmed cell death 1 (PD-1), or their ligands, such as PD …

Cellular reprogramming consists of the conversion of differentiated cells into pluripotent
cells; the so-called induced Pluripotent Stem Cells. iPSC are amenable to in vitro …

Over the last 2 decades, induced pluripotent stem cells (iPSCs) have had various potential
applications in various medical research areas, from personalized medicine to disease …